Generic Drug Analysis & Statistics, January 2015

24/7 Customer Support

Talk to Louis

+1 718 618 4302

All regions

1-30 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Patent Cliff and the Future of Generics in Asia : Trends that will Impact the Market in the Short Term

Patent Cliff and the Future of Generics in Asia : Trends that will Impact the Market in the Short Term

  • $ 3 500
  • Industry report
  • December 2014
  • by Frost & Sullivan

Executive Summary •The generic drug manufacturers in Asia have started looking beyond patent cliff to drive growth. As less drugs are expected to go off patent in 2015-2017, the manufacturers are adopting ...

  • Industries : Generic Drug
Generics: Global Industry Guide

Generics: Global Industry Guide

  • $ 1 495
  • Industry report
  • December 2014
  • by MarketLine

  • Industries : Generic Drug
  • Countries : World
Generics: World Market Overview (Market size, Segmentation and Trends Analysis)

Generics: World Market Overview (Market size, Segmentation and Trends Analysis)

  • $ 1 495
  • Industry report
  • December 2014
  • by MarketLine

It includes detailed data on industry size and sector ation, textual analysis of the key trends and competitive landscape, and profiles of the leading firms . This incisive report provides expert analysis ...

  • Industries : Generic Drug
  • Countries : World
Generic Pharmaceuticals Global - Industry Report

Generic Pharmaceuticals Global - Industry Report

  • $ 1 668
  • Industry report
  • January 2015
  • by Plimsoll Publishing Ltd UK

Plimsoll's GENERIC PHARMACEUTICALS (Global) analysis is the most definitive and accurate study of the GENERIC PHARMACEUTICALS (Global) sector in 2013. The report is split into two sections and uses both ...

  • Industries : Generic Drug
  • Countries : World
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Despite a downgrade in our economic outlook for Serbia, BMI's expenditure projections for the pharmaceutical industry for from 2012 to 2015 are up moderately due to revisions to our previous ...

  • Industries : Generic Drug
  • Countries : Serbia and Montenegro
Mexico Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Mexico Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Despite our generally positive outlook for much of Latin America in 2012, we maintain the view that mounting fiscal pressures and a faltering business environment will damage Mexico’s attractiveness ...

  • Industries : Generic Drug
  • Countries : Mexico
Philippines Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Philippines Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: Despite the government's commitment to providing affordable medical treatment for the population, the vast majority of people continue to have poor access to adequate healthcare. This is primarily ...

  • Industries : Generic Drug
  • Countries : Philippines
Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: Out-of-pocket spending will continue to be the main driver behind the growth of Bulgaria’s pharmaceutical industry, though this feature also makes the industry highly vulnerable to the wide ...

  • Industries : Generic Drug
  • Countries : Bulgaria
World Generic Markets 05 JANUARY 2015

World Generic Markets 05 JANUARY 2015

  • $ 1 114
  • Industry report
  • January 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - National And International Legislation To Mould Generic Industry In 2015 Industry Brief - Teva Launches Erlotinib In Canada Industry Brief - Par Adds Name To Trokendi XR Patent ...

  • Industries : Generic Drug
  • Countries : World, United States
Generic Pharmaceutical Manufacturing Market in the United States

Generic Pharmaceutical Manufacturing Market in the United States

  • $ 1 020
  • Industry report
  • December 2014
  • by Ibisworld

IBISWORLD INDUSTRY RISK RATINGS REPORT This is the replacement for IBISWorld's March Generic Pharmaceutical Manufacturing in the US Industry Risk Ratings Report. Industry Risk Ratings Synopsis This Industry ...

  • Industries : Generic Drug
  • Countries : United States
Brazil Pharmaceutical Market Outlook 2018

Brazil Pharmaceutical Market Outlook 2018

  • $ 1 000
  • Industry report
  • December 2014
  • by RNCOS

Brazil is considered as one of the most lucrative healthcare markets, accounting for the highest healthcare expenditure in Latin America. It is the largest pharmaceutical market in Latin America and the ...

  • Industries : Generic Drug
  • Countries : Brazil
Fesoterodine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Fesoterodine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Frovatriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Frovatriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Galantamine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Galantamine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Ibandronic Acid  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Ibandronic Acid - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Imatinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Imatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Lasofoxifene  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Lasofoxifene - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Pitavastatin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Pitavastatin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Prasugrel  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Prasugrel - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Rizatriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Rizatriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Valganciclovir  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Valganciclovir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Eletriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Eletriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Losartan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Losartan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Tamsulosin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Tamsulosin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Tolterodine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Tolterodine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Zoledronic Acid  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Zoledronic Acid - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Zolmitriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Zolmitriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Febuxostat  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Febuxostat - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Rasagiline  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Rasagiline - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Silodosin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Silodosin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
About 200 reports

Download Unlimited Documents from Trusted Public Sources

Biosimilars Market Forecast in Europe

  • September 2014
    2 pages
  • Biosimilars  

    Drug  

  • Europe  

    Spain  

    World  

View report >

Generic Drug Industry

January 2014

6 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Mylan Inc.

United States

Teva Pharmaceuticals

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.